𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Retrospective evaluation of the dose of dysport and BOTOX in the management of cervical dystonia and blepharospasm: The REAL DOSE study

✍ Scribed by Albert Marchetti; Raf Magar; Leslie Findley; Jan P. Larsen; Zvezdan Pirtosek; Evzen Råužižka; Robert Jech; Jaroslaw Sławek; Fayyaz Ahmed


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
158 KB
Volume
20
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The purpose of this study is to evaluate the real‐world dose utilization of Dysport and BOTOX for cervical dystonia and blepharospasm. Six investigational sites (five countries) were identified. Investigators abstracted utilization data for patients who received Dysport before switching to BOTOX or BOTOX before switching to Dysport. Patients were identified during scheduled clinic visits and selected if they met study criteria, which included treatment for at least 2 consecutive years (at least 1 year with Dysport or BOTOX, then switched and maintained on BOTOX or Dysport for at least another year). A total of 114 patients were included in the assessment. Ratios of mean dose for Dysport to BOTOX ranged from a low of 2:1 to a high of 11:1. Thirty‐one percent of patients fell into the Dysport‐to‐BOTOX ratio grouping of 5:1 to less than 6:1; 30% of patients had a mean ratio of Dysport to BOTOX of 4:1 to less than 5:1; and only 21% of all patients evaluated fell into the Dysport‐to‐BOTOX ratio grouping of 3:1 to less than 4:1. Results are consistent with United Kingdom labeling for botulinum toxins stating that units of different serotype A toxins are not interchangeable and simple dose‐conversion factors are not applicable. © 2005 Movement Disorder Society


📜 SIMILAR VOLUMES


Retrospective evaluation of the dose of
✍ Albert Marchetti; Raf Magar; Leslie Findley; Jan P. Larsen; Zvezdan Pirtosek; Ev 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 34 KB

## Abstract The original article to which this Erratum refers has been published in __Movement__ DisordersMov Disord (2005) 20 (8) 937–934. © 2005 Movement Disorder Society

The phenomenology of the geste antagonis
✍ Davide Martino; Daniele Liuzzi; Antonella Macerollo; Maria Stella Aniello; Paolo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

## Abstract The geste antagoniste (GA), a relatively common feature of adult‐onset primary dystonia, has been systematically evaluated only in cervical dystonia, but it is still unclear whether its frequency and phenomenology differ among the various forms of focal dystonia. We analysed the frequen

Efficacy and safety of botulinum type A
✍ Daniel Truong; Drake D. Duane; Joseph Jankovic; Carlos Singer; Lauren C. Seeberg 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

## Abstract Botulinum toxin type A (Dysport) has been shown in European studies to be a safe and effective treatment for cervical dystonia. This multicenter, double‐blind, randomized, controlled trial assessed the safety and efficacy of Dysport in cervical dystonia patients in the United States. Ei

Debt management in Brazil: evaluation of
✍ Afonso S. Bevilaqua; Márcio G.P. Garcia 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 345 KB

## Abstract The Brazilian domestic debt has posed two challenges to policy‐makers: it has grown very fast and its maturity is extremely short. This has prompted fears that a default or a compulsory lengthening scheme would be imposed. Here, we analyse the domestic public debt management experience